It was reported that the expression of wnt11 was apparently up-regulated in CRC tumors, and its content was positively correlated with poor CRC prognosis, which made wnt11 a potential biomarker and therapeutic target in CRC47. The gene discussed is WNT11; the disease is colorectal carcinoma.